Paydirt
KR
Insider

Keith Regnante

CHIEF FINANCIAL OFFICER

Keith Regnante (CHIEF FINANCIAL OFFICER) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale, 1 filed past the two-business-day deadline), most often in KROS.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.8M
shares × price, as filed
Last traded
Jan 4 2024
Filed Jan 24 2025
Open performance→
Volume by month
$1.8M$906K$0Oct 2024Apr 2025Oct 2025Apr 2026Jan 2025 · sells $1.8M
Buys $0 Sells $1.8M

Shares × price, as filed · by filing month · past 24 months

Most traded names
KROS KROS KROS · 0 buys · 1 sell 1 filing
Recent filings
KROSSALE Keros Therapeutics, Inc. View filing → $1.8M
40,000 sh × $45.29
Exec Jan 4 2024
Filed Jan 24 2025 · 5:30 PM ET †